Appian Provides New Digital Solution for Pharmacovigilance Reporting to Bayer
June 28 2018 - 8:18AM
Appian (NASDAQ:APPN) today announced that Bayer’s Pharmaceuticals
division has selected the Appian application platform to digitize
and optimize its processes for requesting internal reports on
pharmacovigilance (PV) data.
Complex IT systems, deployed over decades, often work in
isolation and support just a very little piece of a process
landscape. They focus on the specialties of their data types but
not on people, their collaboration and sequence of activities.
People have to remember many rules and process steps when they
combine data manually from different sources.
By focusing on people and their collaboration, solutions built
on Appian help to accelerate business improvement while providing
the flexibility to review, improve processes and rules
continuously. Tracking Key Performance Indicators (KPIs) is an
integral part of all process implementations, providing insights
and visibility across the business.
Appian delivers the starting point and comprehensive insights
into the operational processes for generating listings and
aggregate statistics on side effects, their medical contents and
processing efforts. Appian offers modern interfaces that are
powerful yet easy to use.
Appian’s solution automates recurring decisions based on rules
and supports approvals from mobile devices when required. As a
result, tasks can be completed more efficiently while spending more
time on higher value activities.
“The pharmaceutical industry has realized that it needs to
implement digital technologies to remain competitive and
successful. Increasingly strict regulations, cost pressure, and
rising patient expectations challenge organizations. They are only
able to fulfill these demands if the processes used for
implementing rules and regulations are being simplified and
streamlined – thereby ensuring pharmaceutical companies’
competitive edge,” said Evi Cohen, VP of Global Pharmaceuticals and
Life Sciences, Appian.
About AppianAppian provides a leading low-code
software development platform that enables organizations to rapidly
develop powerful and unique applications. The applications created
on Appian’s platform help companies drive digital transformation
and competitive differentiation. For more information, visit
www.appian.com.
For more press-related information, please contact:
Nicole Greggs Director of Media Relations +1
703.260.7868 Nicole.Greggs@appian.com
Appian (NASDAQ:APPN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Appian (NASDAQ:APPN)
Historical Stock Chart
From Jul 2023 to Jul 2024